BioMarin Pharmaceutical Inc.’s closest tracked peers in the AskCyborg corpus, with each peer’s Cyborg Score (1–10) from a bull-vs-bear AI analyst debate. Highest-scored: Alnylam Pharmaceuticals (8/10), Biogen (7/10), Regeneron Pharmaceuticals (7/10).
| Competitor | Cyborg Score | Industry | Why they compete |
|---|---|---|---|
| Alnylam Pharmaceuticals | 8/10 | Biopharmaceuticals - RNA Interference (RNAi) Therapeutics | RNAi therapeutic platform |
| Biogen | 7/10 | Biopharmaceuticals | Neurology and rare disease therapies |
| Regeneron Pharmaceuticals | 7/10 | Biopharmaceuticals & Therapeutics - Specialty Pharma | Monoclonal antibodies and biologics |
| Ultragenyx Pharmaceutical | 6/10 | Biopharmaceutical - Rare and Ultra-Rare Genetic Disease Therapeutics | Rare genetic disease therapies |
Read the full BioMarin Pharmaceutical Inc. research report.
Cyborg Scores (1–10) are synthesized by AskCyborg’s multi-agent analyst-debate framework across 11 dimensions, recalibrated weekly. How the score works · Methodology.